Prescriber Scope of Practice for Insomnia in Texas

If you’re a psychiatrist or PMHNP wondering whether you can legally treat insomnia patients online—and prescribe controlled sleep medications through telehealth—the short answer is yes, you can. But the longer answer involves understanding federal DEA rules, state-specific prescribing laws, and how your scope of practice plays into it.

Here’s what you actually need to know to practice legally, protect your license, and build a sustainable insomnia telehealth practice in 2026.

Federal Telehealth Rules: The DEA Extensions You Need to Know

The Ryan Haight Act normally requires an in-person visit before prescribing controlled substances. This 2008 law was designed to stop online pill mills, and it made telehealth prescribing of Schedule II–V drugs essentially impossible without that initial face-to-face exam.

Then COVID-19 happened. The DEA suspended that requirement in March 2020, allowing providers to prescribe controlled substances—including common insomnia medications like zolpidem (Ambien), eszopiclone (Lunesta), and temazepam—via telehealth without any prior in-person visit.

Here’s where we stand in 2026:

The DEA has extended these COVID-era flexibilities through December 31, 2026. That means you can legally prescribe Schedule II–V controlled substances to new patients via live audio-video telemedicine, as long as you’re following your state’s laws and meeting the standard of care.

This isn’t permanent yet. The DEA is working on a final regulatory framework that will likely include a ‘Special Registration’ for telemedicine prescribing. Under the proposed rules announced in January 2025:

• Any DEA-registered provider could apply for a Telemedicine Special Registration to prescribe Schedule III–V controlled substances (which covers most insomnia meds) without an in-person exam
• Psychiatrists specifically would be eligible for an Advanced Telemedicine Registration to prescribe Schedule II substances as well
• A national PDMP system would provide additional safeguards

But those rules aren’t finalized. For now, you’re operating under the temporary extension, which gives you wide latitude to treat insomnia via telehealth.

What this means for your practice: You can start an insomnia patient on a Schedule IV sleep medication (zolpidem, eszopiclone, etc.) after a thorough video evaluation. You don’t need to see them in person first. Just document your assessment, check your state’s PDMP, and prescribe according to standard clinical guidelines.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Insomnia Medications: What You’re Actually Prescribing

Most insomnia medications fall into Schedule IV of the federal Controlled Substances Act. These are considered lower-risk than opioids or stimulants, but they’re still regulated:

Common Schedule IV Insomnia Drugs:

• Z-drugs (non-benzodiazepine hypnotics): Zolpidem (Ambien), eszopiclone (Lunesta), zaleplon
• Benzodiazepines: Temazepam (Restoril), triazolam
• Orexin receptor antagonists: Suvorexant (Belsomra), lemborexant

Non-controlled options like trazodone, doxepin (low-dose), and ramelteon can be prescribed via telehealth without any controlled-substance restrictions—but when patients have severe, chronic insomnia, you often need the Schedule IV medications.

What You Need to Prescribe Legally

1. DEA registration in the state where your patient is located
2. State medical or nursing license in that state
3. PDMP check before prescribing (required in most states)
4. Standard of care documentation: Sleep history, ruling out medical causes (like sleep apnea), discussion of behavioral strategies, rationale for medication choice

The federal rules allow you to e-prescribe these medications after a telehealth visit. You’re not limited to certain quantities or durations federally (though some states impose limits—more on that below).

Psychiatrist Scope: You’re Fully Authorized

As a psychiatrist, treating insomnia is squarely within your scope of practice. No state restricts you from diagnosing and managing sleep disorders—in fact, many insomnia cases have psychiatric underpinnings (anxiety, depression, racing thoughts) that you’re uniquely qualified to address.

You can:

• Conduct comprehensive sleep evaluations via telehealth
• Provide cognitive behavioral therapy for insomnia (CBT-I) or sleep hygiene counseling
• Prescribe any necessary medications, controlled or not
• Manage complex cases where insomnia co-occurs with other psychiatric conditions

You don’t need supervision, collaboration, or special certification to treat insomnia. Your medical license and DEA registration are sufficient. The only requirement is meeting the standard of care—which means doing a proper assessment (sleep history, screening for medical causes like apnea or restless legs, reviewing medication/substance use) and documenting your clinical reasoning.

The Standard of Care via Telehealth

State medical boards and the DEA expect telehealth to meet the same standard as in-person care. For insomnia, that means:

• Thorough evaluation: Sleep patterns, duration, impact on functioning, medical/psychiatric history, substance use
• Ruling out medical causes: Screen for sleep apnea (snoring, obesity, daytime sleepiness), restless legs syndrome, pain conditions, medication side effects
• First-line treatments: Discussing behavioral strategies (sleep hygiene, stimulus control, sleep restriction) and possibly recommending CBT-I
• Medication as adjunct: Prescribing controlled hypnotics conservatively—lowest effective dose, shortest appropriate duration, with periodic re-evaluation

Document all of this. If a state medical board ever reviews your practice, they’ll want to see that you conducted a real evaluation via video, not just handed out prescriptions.

PMHNP Scope: It Depends on Your State

Psychiatric Mental Health Nurse Practitioners can absolutely treat insomnia and prescribe sleep medications—but your ability to do so independently varies dramatically by state.

Full Practice Authority States (for Experienced NPs)

In New York and Illinois, experienced PMHNPs can practice and prescribe completely independently:

• New York: After 3,600 hours of practice under a collaborative agreement (about 2 years full-time), you can practice and prescribe independently. No physician oversight needed.
• Illinois: After 4,000 hours of practice and additional continuing education, you can apply for Full Practice Authority, which includes independent prescribing of controlled substances.

In these states, you can run a solo telehealth insomnia practice. You’ll need your own DEA registration, state APRN license, and controlled substance authority—but you don’t need a supervising physician.

California is transitioning to this model under AB 890. Experienced NPs (3+ years) can now practice independently in certain settings, with full independence possible after meeting additional requirements.

Reduced Practice States

In Pennsylvania, you need a collaborative agreement with a physician to prescribe. The physician doesn’t co-sign every prescription, but the agreement must outline your prescriptive authority and the physician must be available for consultation.

For insomnia care, this means you can manage patients directly and prescribe Schedule IV sleep medications—but you need that physician collaboration on file.

Restricted Practice States

Texas and Florida require more substantial physician oversight:

• Texas: You must have a written Prescriptive Authority Agreement with a supervising physician. You cannot prescribe Schedule II controlled substances in outpatient settings (not relevant for most insomnia care, which uses Schedule IV). You can prescribe Schedule III–V under physician delegation.

• Florida: PMHNPs require a supervising physician’s written protocol. Florida created an ‘autonomous APRN’ pathway in 2020, but it excluded psychiatric NPs—only certain primary care NPs can practice independently. As of 2026, there’s pending legislation (SB 758) to extend autonomy to psychiatric NPs, but it hasn’t passed yet.

The bottom line for NPs: Check your state’s practice authority. If you can practice independently, telehealth insomnia care is wide open. If you need collaboration or supervision, you’ll need to partner with a physician—but you can still build a thriving practice within those constraints.

State-by-State Telehealth Prescribing Rules (What Actually Matters)

Federal rules give you the framework, but state laws determine what you can actually do. Here’s what you need to know for the major markets:

California: Permissive, With PDMP Requirements

• Licensing: You must hold a California license (no special telehealth license available)
• NP Independence: AB 890 allows experienced NPs (3+ years) to practice independently as of 2023
• Tele-prescribing controls: No state ban on Schedule IV via telehealth. Schedule II is discouraged without a prior in-person exam, but insomnia rarely involves Schedule II.
• PDMP: Mandatory CURES check before the first prescription of any Schedule II–IV drug, and at least every 4 months for ongoing therapy
• E-prescribing: Required for all controlled substances (with narrow exceptions)

Practical reality: California is telehealth-friendly. You can treat insomnia patients statewide via video, prescribe Ambien or Lunesta after running a CURES query, and e-prescribe directly to their pharmacy. The state has strong telehealth parity laws, so insurance coverage isn’t usually an issue.

Texas: Open for Insomnia, Closed for Pain

• Licensing: Texas license required (or IMLC expedited licensure)
• NP Practice: Restricted—requires physician delegation; no Schedule II prescribing by NPs
• Tele-prescribing: Prohibited for chronic pain management with controlled substances. Insomnia is fine—this restriction targets opioid prescribing for pain, not psychiatric medication management.
• PDMP: Required check before prescribing opioids, benzodiazepines, barbiturates, or (as of 2021 updates) any Schedule III–V controlled substances
• E-prescribing: Mandatory for all controlled drugs since 2021

Practical reality: Texas opened up telehealth significantly in 2017 (SB 1107). You can treat insomnia via telehealth and prescribe Schedule IV sleep meds without issue—just don’t accidentally frame your documentation as ‘chronic pain management.’ Always tie treatment to insomnia or psychiatric indications. NPs need physician agreements, but psychiatrists have full scope.

Florida: The Psychiatric Exception Is Key

• Licensing: Either Florida license or register as an out-of-state telehealth provider (unique to Florida)
• NP Practice: Restricted—PMHNPs need supervising physician protocols (autonomy limited to certain primary care APRNs)
• Tele-prescribing: Florida bans telehealth prescribing of controlled substances except for treating psychiatric disorders, inpatient care, hospice, or nursing homes. Insomnia qualifies as a psychiatric disorder (it’s in the DSM-5), so you can prescribe Schedule IV sleep medications via telehealth under this exception.
• PDMP: Must check E-FORCSE before every controlled substance prescription for patients 16+

Practical reality: Florida’s telehealth registration program is a big advantage—you can treat Florida patients without full Florida licensure. But document clearly that you’re treating insomnia as a psychiatric/mental health condition, not just as a standalone medical symptom. This keeps you within the law’s ‘psychiatric disorder’ exception. NPs need physician oversight, but psychiatrists can practice independently.

New York: Strict PDMP, But Otherwise Straightforward

• Licensing: New York license required (not in IMLC)
• NP Practice: Full authority after 3,600 hours; collaboration required until then
• Tele-prescribing: No state restrictions beyond federal rules
• PDMP: Mandatory ISTOP check before every prescription of Schedule II–IV drugs (not just the first one)
• E-prescribing: Required for all prescriptions

Practical reality: New York embraces telehealth for mental health. You can establish the patient relationship via video and prescribe sleep medications the same day. The ISTOP requirement is more stringent than most states—you need to run it every time, not just initially—but it’s built into most EHR systems now. Experienced PMHNPs can operate solo practices, which is a major draw.

Pennsylvania: Collaboration Required, PDMP Every Time for Benzos

• Licensing: Pennsylvania license (or IMLC expedited licensure)
• NP Practice: Reduced—collaborative agreement required
• Tele-prescribing: No special state restrictions; follow federal rules and standard of care
• PDMP: Must query before initially prescribing opioids or benzodiazepines, and for every subsequent prescription of opioids or benzos (Act 191)

Practical reality: Pennsylvania has no comprehensive telehealth law, but practice is allowed under medical board guidance. If you prescribe a benzodiazepine for sleep (temazepam, lorazepam), you must check the PDMP every single time. For non-benzo hypnotics like zolpidem, it’s encouraged but not legally mandated—though most providers check anyway. NPs need physician collaboration agreements on file.

Illinois: FPA-Friendly and Telehealth-Progressive

• Licensing: Illinois license required (IMLC available for physicians)
• NP Practice: Full Practice Authority available after 4,000 hours and training; otherwise collaborative agreement required
• Tele-prescribing: No unique restrictions; standard patient relationship and documentation required
• PDMP: Mandatory for opioids initially; encouraged for all controlled substances

Practical reality: Illinois implemented Full Practice Authority for APRNs in 2018, and many PMHNPs now practice independently. The state’s telehealth laws are favorable—no in-person requirement, audio-only allowed for mental health in some cases, strong parity protections. You can build a completely independent insomnia practice if you have FPA status.

The Economics: Why Telehealth for Insomnia Makes Sense

Let’s talk numbers—because that’s what determines whether this is worth your time.

The DIY Marketing Reality

If you’re trying to build a private practice the traditional way, patient acquisition is expensive and time-consuming:

• SEO: Takes 6–12 months of consistent investment before generating meaningful patient flow. Most solo providers don’t have the expertise or patience for this.
• Google Ads: Mental health keywords cost $15–40+ per click. Most clicks don’t convert to booked patients. Realistic cost per booked patient through PPC: $200–400+ when you factor in ad spend, testing, optimization, and no-shows.
• Psychology Today: Monthly listing fees, plus you compete with hundreds of other providers on the same page. No guaranteed patient flow.
• Zocdoc: Charges per booking ($35–100+ depending on market) plus monthly subscription fees.

When you add it all up—agency/consultant fees, ad spend, staff time to handle leads, no-show rates, months of investment before results—acquiring a qualified psychiatric patient through DIY marketing typically costs $200–500+ per patient.

And that’s just acquisition cost. You still need:

• Telehealth platform ($50–200/month)
• EHR system ($100–500/month)
• EPCS capability
• Billing infrastructure
• Credentialing with insurers (if taking insurance)
• Administrative staff time

The Klarity Model: Pay Only When You See Patients

Klarity uses a pay-per-appointment model—similar to Zocdoc, but for psychiatric care. Instead of spending thousands per month on marketing with uncertain results, you pay a standard listing fee per new patient lead.

Key value propositions:

• No upfront marketing spend or monthly subscription fees for patient acquisition
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure—no separate platform costs
• Both insurance and cash-pay patient flow
• You control your schedule—only pay when you see patients

Frame it this way: Instead of gambling $3,000–5,000/month on marketing channels that might not work, you pay only when a qualified patient books with you. That’s guaranteed ROI vs. rolling the dice on SEO or Google Ads that may take months to generate a single patient.

For most providers—especially those starting out or scaling—a platform that handles patient acquisition removes the risk entirely. DIY marketing can eventually be cost-effective if you have the budget, expertise, and patience. But if you want to see insomnia patients this month, not six months from now, Klarity’s model makes economic sense.

What Insomnia Care Pays

A typical insomnia intake visit bills at psychiatric diagnostic evaluation codes (90791 or 90792), reimbursing $150–300+ depending on payer and market. Medication management follow-ups (99214/99215 or 90833/90836) reimburse $75–200+.

Cash-pay rates for insomnia care typically run $200–400 for initial consultations, $100–250 for follow-ups.

If you’re treating 10–15 insomnia patients per week through a platform like Klarity, you’re looking at $3,000–6,000+ weekly revenue with none of the marketing headaches. And because insomnia patients often need ongoing medication management (monthly or quarterly follow-ups to adjust doses, manage side effects, address tolerance), they represent recurring revenue—not just one-time visits.

Comparison: Psychology Today vs. Klarity for Insomnia Providers

Bottom line: Psychology Today can work if you’re already established, have good SEO, write compelling profiles, and are patient. Klarity makes sense if you want predictable patient flow starting immediately, don’t want to manage your own marketing, and value the all-in-one infrastructure.

Practical Next Steps: Building Your Insomnia Telehealth Practice

1. Get Licensed in Your Target States

If you want to treat patients in multiple states, you’ll need licenses in each (or use compacts where available). Prioritize states with favorable telehealth laws and large patient populations:

• IMLC states (for physicians): Texas, Pennsylvania, Illinois make it easier to get multi-state licenses
• FPA states (for experienced NPs): New York, Illinois, California allow independent practice

2. Secure DEA Registration in Each State

You need a separate DEA registration for each state where you’ll prescribe controlled substances. Budget about $731 per state for the initial 3-year registration.

3. Set Up PDMP Access

Register for PDMP access in every state where you’ll practice:

• California: CURES
• Texas: PMP AWARxE
• Florida: E-FORCSE
• New York: ISTOP
• Pennsylvania: ABC-MAP
• Illinois: PMPnow

Most states now have interstate PDMP data sharing, but you need to be registered in your primary state.

4. Get EPCS-Capable

Electronic prescribing of controlled substances requires two-factor authentication and DEA-approved identity proofing. Most modern EHR/telehealth platforms (including Klarity) have this built in.

5. Understand Your Scope Limits

• Psychiatrists: You’re good to go anywhere you’re licensed
• PMHNPs in FPA states: Practice independently
• PMHNPs in collaboration states: Get your physician agreement in place before seeing patients

6. Decide: Build or Join?

You can build your own practice from scratch (DIY marketing, your own platform, credentialing, billing) or join an existing telehealth platform like Klarity that handles patient acquisition and infrastructure.

Build if:

• You have 6–12 months and $10,000+ to invest before seeing ROI
• You enjoy marketing and have expertise in SEO/digital advertising
• You want complete control over branding and patient experience

Join Klarity if:

• You want to see patients this month, not next year
• You’d rather focus on clinical care than marketing
• You value predictable patient volume without upfront spend

FAQ: Insomnia Telehealth Prescribing

Can I prescribe Ambien (zolpidem) via telehealth without seeing the patient in person first?

Yes, under the current DEA temporary extension (through December 31, 2026). You must conduct a proper video evaluation, document your clinical reasoning, and check your state’s PDMP before prescribing.

Do I need a special DEA registration for telehealth prescribing?

Not currently. Once the DEA finalizes its permanent telehealth rules (expected by late 2026 or early 2027), there will likely be a ‘Special Registration’ option for prescribing Schedule III–V medications via telehealth. For now, your regular DEA registration is sufficient.

What if my state doesn’t allow telehealth prescribing of controlled substances?

Very few states have outright bans. Florida prohibits it except for psychiatric treatment (which covers insomnia). Texas prohibits it for chronic pain management (but not insomnia). Check your specific state rules, but in most states, psychiatric controlled substance prescribing via telehealth is allowed if you meet the standard of care.

Can I treat insomnia patients in multiple states?

Yes, but you need to be licensed in each state where your patients are located. You also need separate DEA registrations for each state. Consider starting with 1–2 states and expanding as you build patient volume.

As a PMHNP, can I prescribe sleep medications independently?

It depends on your state. In New York (after 3,600 hours), Illinois (with FPA), and California (under AB 890 for experienced NPs), yes. In Texas, Florida, and Pennsylvania, you need physician collaboration or supervision.

What’s the difference between treating insomnia and treating chronic pain via telehealth?

Legally, it’s significant in some states. Texas explicitly bans telehealth prescribing of controlled substances for chronic pain management. Florida allows it for psychiatric disorders but not general pain. Insomnia is classified as a sleep-wake disorder (psychiatric condition), not pain, so these restrictions don’t apply.

Do I need to use CBT-I before prescribing medication?

Clinically, CBT-I is considered first-line treatment for chronic insomnia. From a regulatory perspective, there’s no law requiring you to try therapy first—but best practices suggest discussing behavioral approaches and documenting why medication is appropriate for this patient. This protects you if your prescribing is ever reviewed.

How often do I need to check the PDMP?

It varies by state:

• New York: Every prescription of Schedule II–IV
• Pennsylvania: Every prescription of opioids or benzodiazepines (initial and refills)
• California: First prescription, then every 4 months
• Most other states: At least initially, with periodic checks for ongoing therapy

When in doubt, check every time. It takes 30 seconds and protects your license.

Can I prescribe insomnia medication for patients under 18?

This gets more complicated. Most insomnia medications aren’t FDA-approved for pediatric use (though sometimes used off-label). Some states impose additional requirements for prescribing psychotropic controlled substances to minors. Florida, for example, requires that only psychiatric nurses can prescribe controlled psychotropics to minors—general NPs cannot. Tread carefully and document thoroughly if treating pediatric insomnia.

What happens when the DEA temporary rules expire at the end of 2026?

The DEA is expected to finalize permanent telehealth regulations before then. These will likely include the Special Registration pathway, allowing continued telehealth prescribing of controlled substances under new requirements. The DEA has repeatedly stated they don’t want to disrupt patient care, so some form of telehealth flexibility will almost certainly continue—just under a permanent framework instead of temporary extensions.

The Bottom Line: Opportunity Is Open, But Not Forever

Right now, in early 2026, you have a clear regulatory path to treat insomnia via telehealth and prescribe controlled sleep medications. The federal rules are permissive (through at least the end of 2026), most states allow it, and patient demand is high.

But this window won’t stay open indefinitely. The DEA will finalize permanent rules—likely with additional requirements like special registrations or periodic in-person exams. Some states may impose new restrictions on telehealth prescribing of controlled substances.

If you’ve been thinking about adding insomnia care to your practice or starting a telehealth-focused insomnia service, now is the time.

For psychiatrists: You have full scope, no collaboration requirements, and strong regulatory support. The barrier isn’t legal—it’s patient acquisition and infrastructure.

For PMHNPs: If you’re in a Full Practice Authority state (or eligible for it), you can build an independent practice. If you’re in a restricted state, you’ll need physician oversight—but the clinical opportunity is still there.

The Klarity advantage: Instead of spending months and thousands of dollars trying to figure out marketing, credentialing, telehealth platforms, and billing, you can start seeing pre-qualified insomnia patients immediately. You pay only when patients book, there’s no upfront spend, and all the infrastructure is handled.

Ready to explore joining Klarity’s provider network? We’re actively recruiting psychiatrists and PMHNPs interested in telehealth insomnia care (and broader psychiatric medication management). Learn more about our provider partnership opportunities and see if it’s the right fit for your practice goals.

Sources and References

1. DEA Press Release – ‘DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care’ (Dec 31, 2025)
   https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care
   Official DEA announcement extending COVID-era telehealth prescribing rules through December 31, 2026

2. DEA Press Release – ‘DEA Announces Three New Telemedicine Rules to Continue Open Access’ (Jan 16, 2025)
   https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access
   DEA announcement of proposed permanent telehealth regulations including Special Registration pathway

3. Florida Statutes §456.47 – Use of Telehealth to Provide Services
   https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html
   Florida state law defining telehealth practice and controlled substance prescribing exceptions

4. Texas Board of Nursing – APRN Practice FAQs
   https://www.bon.texas.gov/faqpracticeaprn.asp.html
   Texas regulatory guidance on APRN scope, prescriptive authority, and telehealth limitations

5. New York State Education Department – Practice Requirements for Nurse Practitioners
   https://www.op.nysed.gov/professions/nurse-practitioners/professional-practice/practice-requirements
   New York official guidance on NP collaboration requirements and path to independent practice

Source:

• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=WASHINGTON%20%E2%80%93%C2%A0The%20U,flexibilities%20through%20December%2031%2C%202026
• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=Under%20these%20telemedicine%20flexibilities%2C%20DEA,applicable%20federal%20and%20state%20law
• https://www.healthcarefinancenews.com/news/telehealth-prescribing-controlled-drugs-extended-through-2025#:~:text=During%20the%20COVID,person%20evaluation%20of%20that%20patient
• https://www.dlapiper.com/en-th/insights/publications/2024/11/dea-and-hhs-issue-third-temporary-extension-of-telemedicine-flexibilities#:~:text=Further%2C%20as%20the%20Third%20Temporary,monitor%20this%20space%20for%20updates
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=ever%20having%20an%20in,specialized%20medical%20providers%20to%20issue
• https://www.op.nysed.gov/professions/nurse-practitioners/professional-practice/practice-requirements#:~:text=New%20York%20State%20Education%20Law,to%20practice%20under%20physician%20supervision
• https://idfpr.illinois.gov/profs/nursing.html#:~:text=,APN%20Controlled%20Substance
• https://www.op.nysed.gov/professions/nurse-practitioners/professional-practice/practice-requirements#:~:text=Nurse%20practitioners%2C%20however%2C%20must%20practice,or%20certified%20NP%20as%20follows
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=also%20are%20psychiatric%20nurses%20as,455
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=provider%20may%20not%20use%20telehealth,in%20Schedule%20II%20of%20s